Skip to content

A study to evaluate the efficacy of Ayurvedic agents in the management of conditions associated with bone weakness and decreased bone mineral density leading to fractures.

A Comparative Clinical Study Of Vrishmooladi Taila Matra Basti and Asthisharinkhala Gharita Guggulu In the Management of Osteoporosis & Osteopenia

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/08/009573
Enrollment
45
Registered
2017-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- osteopenia and osteoporois Health Condition 2: M818- Other osteoporosis without currentpathological fracture

Interventions

Intervention1: Group A: Three courses of 60 ml of vrishmooladi tila matra basti for 15 days at the interval of 3days. Intervention2: Group B: Three courses Asthisharinkhala Gharita Guggulu 1gram BD f

Sponsors

uttarakhand ayurveda university
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.BMD score( T 2. Having clinical feature of osteoporosis, Asthi-Majja Kshaya- Extreme fatigue (Shrama) Body pain (Asthi Shool) Hair loss (Kesha Patan) Forward bending of spine (Vinaman) Pain in back Fracture after minimal trauma(Asthi Shiryantam) Looseness of joints (Sandhi Shaithilya)

Exclusion criteria

Exclusion criteria: 1. Age group 2. Known case of Hyperparathyroidism. 3. Known case of Osteomalacia, rickets. 4. Genetic Cause. 5. Known of Cushing syndrome and Marfanâ??s syndrome 6. Known case of Thyrotoxicosis

Design outcomes

Primary

MeasureTime frame
To assess the effect of therapy all sign and symptoms were given scoring depending upon there severity. 1. Complete relief : 100% 2. Marked improvement : 76% to 99 3. Moderate improvement : 51% to 75 % 4. Mild improvement : 26 % to 50 % 5. No improvement : 0% to 25 %Timepoint: 51 days

Secondary

MeasureTime frame
Exacerbation in signs and synptomsTimepoint: 1 month

Countries

India

Contacts

Public ContactKshiteeja Choudhary

Rishikul campus,Haridwar

choudharykshiteeja@gmail.com7409774521

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026